Skip to main content
. 2020 Mar 5;10:4100. doi: 10.1038/s41598-020-60942-2

Table 1.

Number of patients per site and characteristics of enrolled TB DOTS patients.

Metro Manila region (N = 338) Negros Occidental region (N = 299) Total (N = 637) p-value1
Centre San Nicolas 108
Pedro Gil 102
San Lazaro Hospital 128
Bago City 222
Valladolid 77
Sex Female 97 (28.7) 94 (31.4) 191 (30.0) 0.488
Male 241 (71.3) 205 (68.6) 446 (70.0)
Age (years) 18–40 183 (54.1) 89 (29.8) 272 (42.7) <0.001
41–65 127 (37.6) 154 (51.5) 281 (44.1)
>65 28 (8.3) 56 (18.7) 84 (13.2)
Household size mean (SD) 4.7 (3.1) 4.7 (2.2) 4.7 (2.7) 0.972
Marital status Single 171 (50.6) 87 (29.1) 258 (40.5) <0.001
Married 132 (39.1) 165 (55.2) 297 (46.6)
Divorced/separated 8 (2.4) 6 (2.0) 14 (2.2)
Widowed 27 (8.0) 41 (13.7) 68 (10.7)
Highest level of education obtained Primary 63 (18.6) 155 (51.8) 218 (34.2) <0.001
Secondary 147 (43.5) 104 (34.8) 251 (39.4)
Tertiary 120 (35.5) 27 (9.0) 147 (23.1)
Vocational 8 (2.4) 13 (4.3) 21 (3.3)
Health insurance2 No 145 (45.7) 98 (33.2) 243 (39.7) 0.002
Yes 172 (54.3) 197 (66.8) 369 (60.3)
Time to health clinic (minutes), median (range) 15 (0–300) 6 (1–120) 10 (0–300) <0.001
Smoking status No or Ex 304 (89.9) 209 (69.9) 513 (80.5) <0.001
Yes 34 (10.1) 90 (30.1) 124 (19.5)
Alcohol consumption Daily 25 (7.4) 92 (30.8) 117 (18.4) <0.001
Weekly or monthly 78 (23.1) 61 (20.4) 139 (21.8)
Rarely/Never 235 (69.5) 146 (48.8) 381 (59.8)
Weight change last 3–6 months3 No change 70 (20.8) 32 (10.7) 102 (16.0) <0.001
Increase 73 (21.7) 18 (6.0) 91 (14.3)
Decrease 194 (57.6) 249 (83.3) 443 (69.7)
Food intake last 1 month3 No change 196 (58.2) 43 (14.4) 239 (37.6) <0.001
Increase 66 (19.6) 79 (26.4) 145 (22.8)
Moderate decrease 65 (19.3) 98 (32.8) 163 (25.6)
Severe decrease 10 (3.0) 79 (26.4) 89 (14.0)
Household Food security score Secure 218 (64.5) 108 (36.1) 326 (51.2) <0.001
Moderate insecurity 69 (20.4) 98 (32.8) 167 (26.2)
Severe insecurity 51 (15.1) 93 (31.1) 144 (22.6)
Multi-drug resistant TB No 305 (90.2) 299 (100.0) 604 (94.8) <0.001
Yes 33 (9.8) 0 (0) 33 (5.2)
Previous TB4 New case 206 (61.5) 187 (62.8) 393 (62.1) 0.806
Relapse case 129 (38.5) 111 (37.3) 240 (37.9)
Bacteriologically confirmed TB5 No 198 (60.2) 210 (70.2) 408 (65.0) 0.009
Yes 131 (39.8) 89 (29.8) 220 (35.0)
Treatment phase6 Intensive 199 (58.9) 133 (44.5) 332 (52.1) <0.001
Continuation 139 (41.1) 166 (55.5) 305 (47.9)

Data are n (%) of non-missing values for each characteristic, unless otherwise indicated as mean (SD) or median (range).

1p-value from Fishers exact test for categorical variables, t-test to compare means or Wilcoxon rank sum test to compare medians.

221 missing values in Metro Manila region and 4 missing values in Negros Occidental region.

31 missing value in Metro Manila region.

43 missing value in Metro Manila and 1 missing value in Negros Occidental region.

59 missing values in Metro Manila region.

6Intensive treatment phase, unless extended, is the first 2 months of the 6 month standard TB-DOTS shorter regimen comprising isoniazid, rifampicin, pyrazinamide and ethambutol, followed by continuation phase comprising isoniazid and rifampicin only. The intensive phase of the 9/12 months WHO shorter regimen for multi-drug resistant TB is the first 4 months (unless extended) comprising kanamycin, moxifloxacin, prothionamide, clofazimine, pyrazinamide and high dose isoniazid and ethambutol followed by continuation phase comprising moxifloxacin, clofazimine, pyrazinamide and ethambutol only.